39 related articles for article (PubMed ID: 2784064)
1. Expression of CD13/aminopeptidase N in precursor B-cell leukemia: role in growth regulation of B cells.
Saxena A; Rai A; Raina V; Seth T; Mitra DK
Cancer Immunol Immunother; 2010 Jan; 59(1):125-35. PubMed ID: 19562339
[TBL] [Abstract][Full Text] [Related]
2. B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy.
Carulli G; Marini A; Ferreri MI; Azzarà A; Ottaviano V; Lari T; Rocco M; Giuntini S; Petrini M
Hematol Rep; 2012 Jul; 4(3):e15. PubMed ID: 23087804
[TBL] [Abstract][Full Text] [Related]
3. NCL-CD10-270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue.
McIntosh GG; Lodge AJ; Watson P; Hall AG; Wood K; Anderson JJ; Angus B; Horne CH; Milton ID
Am J Pathol; 1999 Jan; 154(1):77-82. PubMed ID: 9916921
[TBL] [Abstract][Full Text] [Related]
4. Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia.
Tan K; Xu J; Chen C; Vincent T; Pölönen P; Hu J; Yoshimura S; Yu W; Sussman J; Chen CH; Li E; Diorio C; Shraim R; Newman H; Uppuluri L; Li A; Chen G; Bandyopadhyay S; Wu D; Ding YY; Xu J; Lim T; Hsu M; Thadi A; Ahn KJ; Wu CY; Peng J; Sun Y; Wang A; Mehta R; Frank D; Meyer L; Loh M; Raetz E; Chen Z; Wood B; Devidas M; Dunsmore K; Winter S; Chang TC; Wu G; Pounds S; Zhang N; Carroll W; Hunger S; Bernt K; Yang J; Mullighan C; Teachey D
Res Sq; 2023 Oct; ():. PubMed ID: 37961674
[TBL] [Abstract][Full Text] [Related]
5. Tet2 is a tumor suppressor in the pre-leukemic phase of T-cell acute lymphoblastic leukemia.
De Coninck S; Roels J; Lintermans B; T'Sas S; Taghon T; Curtis DJ; Pieters T; Goossens S; Van Vlierberghe P
Blood Adv; 2024 Mar; ():. PubMed ID: 38536906
[TBL] [Abstract][Full Text] [Related]
6. Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.
Paietta E; Roberts KG; Wang V; Gu Z; Buck GAN; Pei D; Cheng C; Levine RL; Abdel-Wahab O; Cheng Z; Wu G; Qu C; Shi L; Pounds S; Willman CL; Harvey R; Racevskis J; Barinka J; Zhang Y; Dewald GW; Ketterling RP; Alejos D; Lazarus HM; Luger SM; Foroni L; Patel B; Fielding AK; Melnick A; Marks DI; Moorman AV; Wiernik PH; Rowe JM; Tallman MS; Goldstone AH; Mullighan CG; Litzow MR
Blood; 2021 Sep; 138(11):948-958. PubMed ID: 33895809
[TBL] [Abstract][Full Text] [Related]
7. Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children's Oncology Group.
Matloub Y; Rabin KR; Ji L; Devidas M; Hitzler J; Xu X; Bostrom BC; Stork LC; Winick N; Gastier-Foster JM; Heerema NA; Stonerock E; Carroll WL; Hunger SP; Gaynon PS
Blood Adv; 2019 Jun; 3(11):1647-1656. PubMed ID: 31160295
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia.
Uckun FM; Myers DE; Qazi S; Ozer Z; Rose R; D'Cruz OJ; Ma H
J Clin Invest; 2015 Mar; 125(3):1006-18. PubMed ID: 25621496
[TBL] [Abstract][Full Text] [Related]
9. Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Matloub Y; Bostrom BC; Hunger SP; Stork LC; Angiolillo A; Sather H; La M; Gastier-Foster JM; Heerema NA; Sailer S; Buckley PJ; Thomson B; Cole C; Nachman JB; Reaman G; Winick N; Carroll WL; Devidas M; Gaynon PS
Blood; 2011 Jul; 118(2):243-51. PubMed ID: 21562038
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
Matloub Y; Lindemulder S; Gaynon PS; Sather H; La M; Broxson E; Yanofsky R; Hutchinson R; Heerema NA; Nachman J; Blake M; Wells LM; Sorrell AD; Masterson M; Kelleher JF; Stork LC;
Blood; 2006 Aug; 108(4):1165-73. PubMed ID: 16609069
[TBL] [Abstract][Full Text] [Related]
11. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.
Sun L; Heerema N; Crotty L; Wu X; Navara C; Vassilev A; Sensel M; Reaman GH; Uckun FM
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):680-5. PubMed ID: 9892693
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia.
Uckun FM; Jaszcz W; Chandan-Langlie M; Waddick KG; Gajl-Peczalska K; Song CW
J Clin Invest; 1993 Mar; 91(3):1044-51. PubMed ID: 8450034
[TBL] [Abstract][Full Text] [Related]
13. E2A expression, nuclear localization, and in vivo formation of DNA- and non-DNA-binding species during B-cell development.
Jacobs Y; Vierra C; Nelson C
Mol Cell Biol; 1993 Dec; 13(12):7321-33. PubMed ID: 8246953
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 7 receptor engagement stimulates tyrosine phosphorylation, inositol phospholipid turnover, proliferation, and selective differentiation to the CD4 lineage by human fetal thymocytes.
Uckun FM; Tuel-Ahlgren L; Obuz V; Smith R; Dibirdik I; Hanson M; Langlie MC; Ledbetter JA
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6323-7. PubMed ID: 2068112
[TBL] [Abstract][Full Text] [Related]
15. Early embryonal/fetal lymphopoietic ontogeny and leukemogenesis.
Prindull G
Ann Hematol; 1991 Dec; 63(6):291-6. PubMed ID: 1721840
[No Abstract] [Full Text] [Related]
16. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues.
Uckun FM; Muraguchi A; Ledbetter JA; Kishimoto T; O'Brien RT; Roloff JS; Gajl-Peczalska K; Provisor A; Koller B
Blood; 1989 Mar; 73(4):1000-15. PubMed ID: 2784064
[TBL] [Abstract][Full Text] [Related]
17. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
18. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
[TBL] [Abstract][Full Text] [Related]
19. Immunobiologic differences between normal and leukemic human B-cell precursors.
Uckun FM; Ledbetter JA
Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8603-7. PubMed ID: 2460871
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
